Research Articles | Page 16 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia Dec 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation aplastic anemia
Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents Dec 2020 Leukemia Research myelodysplastic syndromes (MDS)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Nov 2020 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Nov 2020 Annals of Oncology: Official Journal of the European Society for Medical Oncology myelodysplastic syndromes (MDS)
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances myelodysplastic syndromes (MDS)
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease Nov 2020 British Journal of Haematology paroxysmal nocturnal hemoglobinuria (PNH)
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management Nov 2020 American Journal of Hematology myelodysplastic syndromes (MDS)
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience Nov 2020 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications Nov 2020 Cells myelodysplastic syndromes (MDS)
Share with addtoany.com.